Profil
Dr. Gaurav Gupta, MD, is a Managing Partner at JP Morgan Life Sciences Private Capital.
He is on the Board of Directors at NewAmsterdam Pharma BV.
Dr. Gupta was previously employed as an Associate by OrbiMed Advisors Private Equity.
He also served on the board at NewAmsterdam Pharma Co. NV.
He received his undergraduate degree from The Johns Hopkins University, a graduate degree from The Johns Hopkins University and a doctorate degree from Stanford University School of Medicine.
Aktive Positionen von Gaurav Gupta
| Unternehmen | Position | Beginn |
|---|---|---|
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gaurav Gupta
| Unternehmen | Position | Ende |
|---|---|---|
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private-Equity-Analyst | 01.01.2019 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Gaurav Gupta
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NewAmsterdam Pharma Co. NV
NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
















